Central Nervous System (CNS) Stimulant Drugs Market Size & Share, by Type (Amphetamines, Methylphenidate), End User (Adolescents, Adults, Hospitals) - Global Supply & Demand Analysis & Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5524
  • Published Date: Jan 11, 2024
  • Report Format: PDF, PPT

Companies Dominating the Central Nervous System (CNS) Stimulant Drugs Market

top-features-companies
    • Shire Pharmaceuticals LLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Novartis International AG
    • Johnson & Johnson
    • Eli Lilly and Company
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Teva Pharmaceutical Industries Ltd.
    • AbbVie Inc.
    • Purdue Pharma L.P.
    • Mallinckrodt Pharmaceuticals


In-the-news

In The News

  • Novartis acquired The Medicines Company for USD 7.6 billion, gaining Ziextenz™, a heart failure treatment with potential for expanded applications. This strengthened Novartis' cardiovascular offerings and positioned them for growth in this sector.
  • Novartis merged its generics business with Sandoz, creating a global generics leader with a strengthened market position and increased efficiency. This streamlined structure optimized resource allocation and enhanced competitiveness in the generics market.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5524
  • Published Date: Jan 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing demand for healthcare sector is the major factor driving the market growth.

The market size of central nervous system (CNS) stimulant drugs is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.

The major players in the market Shire Pharmaceuticals LLC, Novartis International AG, Johnson & Johnson, Eli Lilly and Company, Pfizer Inc., GlaxoSmithKline plc, and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying